Llwytho...
Targeting CD44 Augments the Efficacy of Tregs in Autoimmune Diabetes
Curing type 1 diabetes (T1D) will require lasting control of the autoimmune response that destroys insulin-producing islet β-cells. Re-establishing tolerance by restoring/replacing Tregs has significant potential for treatment of T1D but will require strategies to augment and maintain their efficacy...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Immunol Lett |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4323628/ https://ncbi.nlm.nih.gov/pubmed/25447401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.imlet.2014.10.002 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|